Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumour necrosis factor and Crohn's disease.

Literature DB >> 9176068

Tumour necrosis factor and Crohn's disease.

S J Van Deventer¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1997 PMID： 9176068 PMCID： PMC1027115 DOI： 10.1136/gut.40.4.443

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

61 in total

Review 1. Experimental models of inflammatory bowel disease.

Authors: C O Elson; R B Sartor; G S Tennyson; R H Riddell
Journal: Gastroenterology Date: 1995-10 Impact factor: 22.682

Review 2. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors: K J Tracey; A Cerami
Journal: Annu Rev Med Date: 1994 Impact factor: 13.739

3. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.

Authors: E J Breese; C A Michie; S W Nicholls; S H Murch; C B Williams; P Domizio; J A Walker-Smith; T T MacDonald
Journal: Gastroenterology Date: 1994-06 Impact factor: 22.682

4. Polarised interleukin 8 secretion by HT 29/19A cells.

Authors: K M Lammers; J Jansen; P B Bijlsma; M Ceska; G N Tytgat; C L Laboisse; S J van Deventer
Journal: Gut Date: 1994-03 Impact factor: 23.059

5. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing.

Authors: K M Mohler; P R Sleath; J N Fitzner; D P Cerretti; M Alderson; S S Kerwar; D S Torrance; C Otten-Evans; T Greenstreet; K Weerawarna
Journal: Nature Date: 1994-07-21 Impact factor: 49.962

6. Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation.

Authors: N Myatt; G Coghill; K Morrison; D Jones; I A Cree
Journal: J Clin Pathol Date: 1994-05 Impact factor: 3.411

7. Nuclear migration of NF-kappa B correlates with TNF-alpha mRNA accumulation.

Authors: H Albrecht; L B Schook; C V Jongeneel
Journal: J Inflamm Date: 1995

8. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide.

Authors: C C Schuerer-Maly; L Eckmann; M F Kagnoff; M T Falco; F E Maly
Journal: Immunology Date: 1994-01 Impact factor: 7.397

9. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors: F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal: J Exp Med Date: 1994-02-01 Impact factor: 14.307

10. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors: T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal: J Exp Med Date: 1994-04-01 Impact factor: 14.307

116 in total

Review 1. Anti-TNF antibody treatment of Crohn's disease.

Authors: S J van Deventer
Journal: Ann Rheum Dis Date: 1999-11 Impact factor: 19.103

Review 2. Evolutionary biologic therapy for inflammatory bowel disease.

Authors: S B Hanauer
Journal: Curr Gastroenterol Rep Date: 1999-12

3. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.

Authors: N Borruel; M Carol; F Casellas; M Antolín; F de Lara; E Espín; J Naval; F Guarner; J R Malagelada
Journal: Gut Date: 2002-11 Impact factor: 23.059

9. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors: B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal: Clin Exp Immunol Date: 2007-11-07 Impact factor: 4.330

10. [Update: enterogenic spondylarthritis].

Authors: Elisabeth Märker-Hermann
Journal: Z Rheumatol Date: 2021-05-27 Impact factor: 1.372